• ATP in Mitochondrial Regulation: Mechanisms and Translationa

  2026-06-18

  Explore how mechanistic insights into adenosine triphosphate (ATP) and mitochondrial enzyme regulation are reshaping strategies for translational research, with a focus on the interplay between metabolic flux, purinergic signaling, and post-translational control.

• Metformin Hydrochloride Attenuates Vocal Fold Fibrosis via A

  2026-06-17

  This study demonstrates that Metformin Hydrochloride (Metformin HCl) significantly reduces vocal fold fibrosis in a rabbit model by activating the AMPK signaling pathway. These findings provide mechanistic insight and preclinical support for targeting AMPK in fibrotic laryngeal disorders.

• N-MYC/eIF4G1 Axis in inv(16) AML: Mechanistic Insights and I

  2026-06-17

  Peramangalam et al. uncover the pivotal role of the N-MYC/eIF4G1 axis in supporting the survival of inv(16) acute myeloid leukemia (AML) cells. Their mechanistic work demonstrates that targeting the CBFβ-SMMHC fusion protein downregulates MYCN, impairs leukemic viability, and refines the rationale for targeted AML research.

• Z-YVAD-FMK: Unraveling Caspase-1 Inhibition in Pyroptosis an

  2026-06-16

  Explore how Z-YVAD-FMK, a potent caspase-1 inhibitor, advances apoptosis and pyroptosis research with new insights into tumor biology. This article offers a scientific deep dive and practical guidance beyond standard protocols.

• WIP1 Modulation of p38 MAPK Reduces Pyroptosis in AKI

  2026-06-16

  This study reveals that WIP1 phosphatase regulates p38 MAPK signaling, attenuating pyroptosis in sepsis-associated acute kidney injury (AKI). These findings suggest WIP1 as a potential molecular target for mitigating inflammatory renal damage in septic contexts.

• EGCG Nanoparticles Enhance FLASH-RT Efficacy via DNA Damage

  2026-06-15

  The reference study demonstrates that functionalized EGCG nanoparticles (BENPs) significantly boost the antitumor effect of ultra-high dose rate radiotherapy (FLASH-RT) by amplifying DNA double-strand breaks and promoting robust immune activation. These findings suggest BENPs can overcome previous limitations of FLASH-RT and inform next-generation strategies in radioimmunotherapy.

• Intravesical p21 mRNA-LNP Therapy for Bladder Cancer: New In

  2026-06-15

  This study demonstrates that intravesical delivery of p21 mRNA-loaded lipid nanoparticles (LNPs) can restore tumor suppressor function and suppress bladder cancer growth in preclinical models. The findings offer a novel approach to localized mRNA-based tumor suppressor replacement, leveraging the bladder's accessibility for targeted therapy.

• LDN-193189 in Epithelial Progenitor Expansion: Novel Insight

  2026-06-14

  Explore how LDN-193189, a potent ALK inhibitor, enables advanced epithelial progenitor cell expansion and precise BMP pathway modulation. This article uniquely integrates mechanistic depth with translational assay guidance, setting it apart from existing resources.

• Topotecan as First-Line Therapy in Small Cell Lung Cancer: E

  2026-06-13

  This article examines the reference study’s evaluation of topotecan in first-line small cell lung cancer (SCLC) therapy, highlighting its mechanistic rationale, efficacy in clinical trials, and comparative toxicity profiles. Implications for translational oncology are discussed, with a practical bridge to irinotecan-centered workflows in colorectal cancer research.

• Enhancing Plant Cell Protein Stability with Protease Inhibit

  2026-06-12

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) empowers plant scientists to safeguard protein integrity across demanding workflows, including Western blotting and kinase assays. Its broad-spectrum inhibitor composition and EDTA-free formulation ensure high-fidelity results and reproducible protein preservation, even in complex plant extracts.

• Metformin HCl Reduces Vocal Fold Fibrosis via AMPK Modulatio

  2026-06-12

  The reference study demonstrates that Metformin Hydrochloride (Metformin HCl) attenuates vocal fold fibrosis in a rabbit model by activating the AMPK signaling pathway. These findings provide mechanistic insight into metformin’s antifibrotic action, offering a foundation for translational research in vocal fold scarring and AMPK pathway modulation.

• Nullscript: Advancing HDAC Inhibitor Research Beyond Cardiac

  2026-06-11

  Explore how Nullscript, a unique histone deacetylase inhibitor, enables advanced mechanistic insight beyond conventional cardiac and epigenetic studies. This article details its molecular action and strategic value for translational research.

• Masitinib (AB1010): Technical Use in KIT/PDGFR Inhibition Wo

  2026-06-11

  Masitinib (AB1010) is a highly selective phenylaminothiazole-type tyrosine kinase inhibitor designed for research targeting KIT, PDGFRα, and PDGFRβ signaling. It is suited for DMSO-based workflows in cancer, mastocytosis, and inflammatory disease models, but is not appropriate for protocols needing broad-spectrum kinase inhibition or aqueous/ethanol solubility.

• Nilotinib (AMN-107): Precision Workflows for Kinase Research

  2026-06-10

  Nilotinib (AMN-107) empowers researchers to dissect BCR-ABL and KIT-driven signaling in chronic myeloid leukemia and gastrointestinal stromal tumor models with exceptional selectivity. This guide provides actionable workflows, troubleshooting tips, and insights from breakthrough studies to maximize experimental confidence.

• Amyloid Beta-peptide (25-35): Unraveling Microglial Polariza

  2026-06-10

  Explore the role of Amyloid Beta-peptide (25-35) (Aβ25-35) as a precise Alzheimer's disease neurotoxicity model and its direct connection to microglial polarization pathways. This article uniquely integrates assay design and translational insights, advancing beyond standard protocol guides.

601 records 9/41 page Previous Next First page 上5页 678910 下5页 Last page